Literature DB >> 16076524

Isoflurane preconditioning protects motor neurons from spinal cord ischemia: its dose-response effects and activation of mitochondrial adenosine triphosphate-dependent potassium channel.

Hee-Pyoung Park1, Young-tae Jeon, Jung-won Hwang, Hoon Kang, Seung-Woon Lim, Chong-Sung Kim, Yong-Seok Oh.   

Abstract

We examined in a rabbit model of transient spinal cord ischemia (SCI) whether isoflurane (Iso) preconditioning induces ischemic tolerance to SCI in a dose-response manner, and whether this effect is dependent on mitochondrial adenosine triphosphate-dependent potassium (K(ATP)) channel. Eighty-six rabbits were randomly assigned to 10 groups: Control group (n=8) received no pretreatment. Ischemic preconditioning (IPC) group (n=8) received 5 min of IPC 30 min before SCI. The Iso 1, Iso 2 and Iso 3 groups (n=10, 9, 8) underwent 30 min of 1.05, 2.1 and 3.15% Iso inhalation commencing 45 min before SCI. The Iso 1HD, Iso 2HD and Iso 3HD groups (n=9, 9, 8) each received a specific mitochondrial K(ATP) channel blocker, 5-hydroxydecanoic acid (5HD, 20mg/kg), 5 min before each respective Iso inhalation. The 5HD group (n=8) received 5HD without Iso inhalation. The sham group (n=9) had no SCI. SCI was produced by infra-renal aortic occlusion via the inflated balloon of a Swan-Ganz catheter for 20 min. The Iso 1, Iso 2 and Iso 3 groups showed a better neurologic outcome and more viable motor nerve cells (VMNCs) in the anterior spinal cord 72 h after reperfusion than the control group (p<0.05). Iso 3 group showed a better neurologic outcome and more VMNCs than Iso 1 group (p<0.05). And, the Iso 1, Iso 2 and Iso 3 groups showed a better neurologic outcome and higher VMNC numbers than the corresponding Iso 1HD, Iso 2HD and Iso 3HD groups (p<0.05). This study demonstrates that Iso preconditioning protects the spinal cord against neuronal damage due to SCI in a dose-response manner via the activation of mitochondrial K(ATP) channels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076524     DOI: 10.1016/j.neulet.2005.06.072

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

Review 1.  Naturally occurring disk herniation in dogs: an opportunity for pre-clinical spinal cord injury research.

Authors:  Jonathan M Levine; Gwendolyn J Levine; Brian F Porter; Kimberly Topp; Linda J Noble-Haeusslein
Journal:  J Neurotrauma       Date:  2011-03-25       Impact factor: 5.269

2.  Preconditioning of isoflurane on spinal cord ischemia can increase the number of inducible nitric oxide synthase-expressing motor neurons in rat.

Authors:  Yun-Hee Sung; Sang-Hak Lee; Joon-Kyung Sung; Jin-Hee Han; Hong Kim; Chang-Ju Kim; Jong-Man Kang
Journal:  Korean J Anesthesiol       Date:  2010-01-31

3.  Dual effects of isoflurane on proliferation, differentiation, and survival in human neuroprogenitor cells.

Authors:  Xuli Zhao; Zeyong Yang; Ge Liang; Zhen Wu; Yi Peng; Donald J Joseph; Saadet Inan; Huafeng Wei
Journal:  Anesthesiology       Date:  2013-03       Impact factor: 7.892

4.  Paced breathing and phrenic nerve responses evoked by epidural stimulation following complete high cervical spinal cord injury in rats.

Authors:  Tatiana Bezdudnaya; Michael A Lane; Vitaliy Marchenko
Journal:  J Appl Physiol (1985)       Date:  2018-05-17

Review 5.  Ischemic Tolerance of the Brain and Spinal Cord: A Review.

Authors:  Masatoshi Yunoki; Takahiro Kanda; Kenta Suzuki; Atsuhito Uneda; Koji Hirashita; Kimihiro Yoshino
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-09-27       Impact factor: 1.742

6.  Isoflurane suppresses the self-renewal of normal mouse neural stem cells in a p53-dependent manner by activating the Lkb1-p53-p21 signalling pathway.

Authors:  Lengchen Hou; Te Liu; Jian Wang
Journal:  Mol Med Rep       Date:  2015-09-29       Impact factor: 2.952

7.  Protective effect of sevoflurane preconditioning on ischemia-reperfusion injury in patients undergoing reconstructive plastic surgery with microsurgical flap, a randomized controlled trial.

Authors:  Claudia Claroni; Giulia Torregiani; Marco Covotta; Maria Sofra; Alessandra Scotto Di Uccio; Maria E Marcelli; Alessia Naccarato; Ester Forastiere
Journal:  BMC Anesthesiol       Date:  2016-08-22       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.